Company profile
Covalon Technologies Ltd.
OTC: CVALF · Healthcare · Medical - Instruments & Supplies
Canadian filerHQ Mississauga, ONReports USD
#530 of 1,418 Healthcare companies by revenue46th-percentile growth
EA Score
78B+FH 85DQ —GM 62SS 65
v0.1 · 45/100 weight · provisional
↑ return on assets, Altman-Z · ↓ revenue growth (YoY), disclosure history
Methodology →Revenue TTM
$24.9M
Rev growth YoY (TTM)
+5.1%
Net income (FY)
$1.5M
Employees
105
as of 2026-08-20
Market cap
$45.3M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$23.5M32.8M CAD2025
Net income$1.5M2.1M CAD2025
Operating income$1.3M1.8M CAD2025
Total assets$25.9M36.1M CAD2025
Liabilities$3.9M5.4M CAD2025
Equity$22.1M30.7M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Covalon Technologies Ltd.’s revenue?
Covalon Technologies Ltd. booked $23.5M in FY2025 revenue, growing 2.4% year over year — about the middle of the pack among Healthcare companies we track, at a 6.3% net margin.
Peers · Healthcare
Halo Collective Inc.——Precipio, Inc.69BAlumis Inc.35DWellgistics Health, Inc.19DBody and Mind Inc.——NextCure, Inc.38DKey facts
CEOBrent Ashton
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersMississauga, ON
ExchangeOTC: CVALF
Employees105
IPO date2007-04-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.